Clinical Evaluation Reports (CER) for Medical Devices
The scrutiny of clinical evaluations by Notified Bodies has increased with the EU Medical Devices Regulation 2017/745 (MDR). This scrutiny leaves some companies at risk for observations and nonconformities when transitioning from the Medical Devices Directive 93/42/EEC (MDD) to MDR.
Emergo by UL’s webinar will provide an overview of manufacturer responsibilities for clinical evaluation under the MDR, the clinical evaluation process including related Medical Device Coordination Group (MDCG) guidance on equivalence (MDCG 2020-5) and legacy devices (MDCG 2020-6), additional processes/documentation related to clinical evaluation and current experience in the MDR transition period.
This webinar was recorded on October 21, 2021.
Questions? Request more information from our specialists
CONTACT USRelated
-
WATCH NOW: Risk Management according to EN ISO 14971:2012
Since the publication of ISO 13485:2016, risk management is a major concern for maintaining regulatory compliance in major medical device markets.
read more -
ISO 10993-1 and Biocompatibility for Medical Devices
Biocompatibility testing: an intimidating, time-consuming, and, at times, very expensive requirement in most major medical device markets. Biocompa
read more